Ovarian Cancer: A Quest to Extend Remissions
New treatments aim to lengthen remissions and push back recurrences.
New treatments aim to lengthen remissions and push back recurrences.
Young women who have had hormone receptor-positive breast cancer can safely suspend endocrine therapy to try to have a...
Adoptive T-cell therapy shows promise in treating metastatic melanoma.
New oral hormonal therapy offers alternative to injections for some women with metastatic disease.
Hematologist-oncologist Saad Usmani talks about recent approvals for bispecific antibodies to treat multiple myeloma and other blood cancers.
AI has significant implications for medicine, especially for precision cancer care.
The concept of using vaccination to eradicate cancer by instructing the immune system to eliminate malignant cells has been...
Researchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
“Where is the field of cancer research going?” posed Robert Vonderheide, MD, DPhil, as he welcomed attendees to “AACR...
The treatment of cutaneous melanoma has been profoundly transformed by the advent of targeted therapy and immunotherapy, which have...